Further studies are needed to determine the role of the lnc-HIBADH-4/miR-326/CTSD pathway in vivo so that pharmacological agents can be developed to restore this vital process and protect neurons from degeneration in ALS. Here, CTSD is linked to amyotrophic lateral sclerosis.